PMID- 9784049 OWN - NLM STAT- MEDLINE DCOM- 19981216 LR - 20131121 IS - 0926-9959 (Print) IS - 0926-9959 (Linking) VI - 11 IP - 2 DP - 1998 Sep TI - Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports). PG - 177-9 AB - BACKGROUND: Association of different treatments are often used in erythrodermic psoriasis in order to increase the effectiveness and decrease the incidence of side effects due to single drugs. MATERIALS AND METHODS: Three in-patients affected by erythrodermic psoriasis, not responding to cyclosporine, (two patients) and etretinate, (one patient), were treated with the association cyclosporine plus etretinate. RESULTS: Clinical response was prompt to the combined therapy. The two drugs were tapering off gradually over 6 months; the patients maintained the remission for prolonged period. CONCLUSIONS: Combined cyclosporine-etretinate therapy may be considered as an effective and well tolerated treatment of erythrodermic psoriasis in patients not responding to monotherapy regimen. FAU - Kokelj, F AU - Kokelj F AD - Institute of Dermatology, Ospedale di Cattinara, Trieste, Italy. FAU - Plozzer, C AU - Plozzer C FAU - Torsello, P AU - Torsello P FAU - Trevisan, G AU - Trevisan G LA - eng PT - Case Reports PT - Journal Article PL - England TA - J Eur Acad Dermatol Venereol JT - Journal of the European Academy of Dermatology and Venereology : JEADV JID - 9216037 RN - 0 (Dermatologic Agents) RN - 65M2UDR9AG (Etretinate) RN - 83HN0GTJ6D (Cyclosporine) SB - IM MH - Aged MH - Cyclosporine/*therapeutic use MH - Dermatologic Agents MH - Etretinate/*therapeutic use MH - Humans MH - Male MH - Middle Aged MH - Psoriasis/*drug therapy MH - Skin/drug effects/pathology MH - Treatment Outcome EDAT- 1998/10/23 00:00 MHDA- 1998/10/23 00:01 CRDT- 1998/10/23 00:00 PHST- 1998/10/23 00:00 [pubmed] PHST- 1998/10/23 00:01 [medline] PHST- 1998/10/23 00:00 [entrez] AID - S0926-9959(98)00060-9 [pii] PST - ppublish SO - J Eur Acad Dermatol Venereol. 1998 Sep;11(2):177-9.